Can we treat systemic lupus erythematosus and other autoimmune diseases without oral steroids?

Autor:	Maria José Cuadrado, Eugenia Enríquez Merayo, Savino Sciascia, Dario Roccatello
Rok vydání:	2018
Předmět:	musculoskeletal diseases 0301 basic medicine medicine.medical_specialty medicine.medical_treatment Immunology Osteoporosis macromolecular substances biologic chronic damage Glucocorticoid immunosuppression infection osteoporosis side effects sparing agents systemic lupus erythematosus Immunology and Allergy Autoimmune Diseases 03 medical and health sciences 0302 clinical medicine immune system diseases Humans Lupus Erythematosus Systemic Medicine skin and connective tissue diseases Glucocorticoids Randomized Controlled Trials as Topic 030203 arthritis & rheumatology Biological Products business.industry Immunosuppression medicine.disease Dermatology 030104 developmental biology Rituximab business Immunosuppressive Agents hormones hormone substitutes and hormone antagonists medicine.drug
Zdroj:	Expert Review of Clinical Immunology. 14:877-879
ISSN:	1744-8409 1744-666X
DOI:	10.1080/1744666x.2018.1527219
Popis:	Glucocorticoids (GCs) have traditionally been the center of systemic lupus erythematosus (SLE) treatment and they continue to be recommended by the EULAR and ACR as the first-line therapy for sever...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1fcbfe93037f4f1ee6d747eede15c4 https://doi.org/10.1080/1744666x.2018.1527219 Zobrazit plný text záznamu